logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10092624 B1

PDFFull Text
Date of Patent:
Oct. 09, 2018

Filed:

Apr. 22, 2016

Methods of treating cancers with peptide-based modulators

Applicants:

Musc Foundation for Research Development, Charleston, SC (US);

University of South Carolina, Columbia, SC (US);

Inventors:

Robert G. Gourdie, Roanoke, VA (US);

Edie C. Goldsmith, Columbia, SC (US);

L. Jane Jourdan, Roanoke, VA (US);

Joshua Matthew Rhett, Charleston, SC (US);

Michael J. Yost, Charleston, SC (US);

Assignees:

MUSC Foundation for Research Development, Charleston, SC (US);

University of South Carolina, Columbia, SC (US);

Attorney:

Parker Highlander PLLC

Primary Examiner:

Kevin S Orwig

Int. Cl.
CPC ...
A61L 27/22 (2006.01); C08L 77/04 (2006.01); A61P 35/04 (2006.01); A61K 38/17 (2006.01); C07K 7/08 (2006.01); A61L 27/34 (2006.01); A61L 27/54 (2006.01); A61L 31/04 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01); A61L 15/32 (2006.01); A61L 15/44 (2006.01); A61L 17/00 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); C07K 14/47 (2006.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01); A61K 45/06 (2006.01); C07K 7/06 (2006.01); C07K 14/46 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1703 (2013.01); A61K 9/0048 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61L 15/32 (2013.01); A61L 15/44 (2013.01); A61L 17/005 (2013.01); A61L 27/22 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 31/047 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/46 (2013.01); C07K 14/47 (2013.01); C07K 14/4703 (2013.01); A61K 38/00 (2013.01); A61L 2300/25 (2013.01); A61L 2300/252 (2013.01); A61L 2300/412 (2013.01); A61L 2430/16 (2013.01); C07K 2319/035 (2013.01);
Abstract

Provided are peptides that can inhibit collagen synthesis, processing and/or secretion. In some aspects, the therapeutic peptides may be used to treat a cancer such as, e.g., a pancreatic cancer or a glioblastoma.

Find Patent Forward Citations

Gourdie, Robert. (2018). Methods of treating cancers with peptide-based modulators (U.S. Patent No. 10092624). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10092624

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…